Literature DB >> 26422556

Reconstitution of lymphocyte subpopulations after hematopoietic stem cell transplantation: comparison of hematologic malignancies and donor types in event-free patients.

Borae G Park1, Chan-Jeoung Park2, Seongsoo Jang3, Hyun-Sook Chi3, Dae-Young Kim4, Jung-Hee Lee4, Je-Hwan Lee4, Kyoo-Hyung Lee5.   

Abstract

The reconstitution of different immunocyte subsets after hematopoietic stem cell transplantation (HSCT), follows different timelines. We prospectively investigated changes in lymphocyte subsets after HSCT and their associations with primary diagnosis, conditioning regimen, and HSCT type in event-free patients. A total of 95 patients (48 with acute myeloid leukemia, 22 with acute lymphoid leukemia, and 25 with myelodysplastic syndrome) who underwent allogeneic HSCT (34 sibling matched, 37 unrelated matched, and 24 haploidentical HSCT) but did not experience any events such as relapse or death were enrolled in this study. Lymphocyte subpopulations (T cells, helper/inducer T cells, cytotoxic/suppressor T cells, memory T cells, regulatory T cells, natural killer (NK) cells, NK-T cells, and B cells) were quantified by flow cytometry of peripheral blood from recipients 7 days before and 1, 2, 3, 6, and 12 months after HSCT. Leukocyte counts recovered within 1 month after HSCT. However, the number of T and B lymphocytes recovered at 2 months after HSCT. NK cell counts recovered shortly after haploidentical HSCT. However, T lymphocytes and their subpopulations showed delayed recovery after haploidentical HSCT. Lymphocyte subsets showed different sequential patterns according to HSCT type but no differences were seen according to primary diagnosis or conditioning regimen.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Haploidentical stem cell transplantation; Hematopoietic stem cell transplantation; Immune reconstitution; Lymphocyte subpopulation

Mesh:

Substances:

Year:  2015        PMID: 26422556     DOI: 10.1016/j.leukres.2015.09.010

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  14 in total

1.  Impaired T- and NK-cell reconstitution after haploidentical HCT with posttransplant cyclophosphamide.

Authors:  Benedetta Rambaldi; Haesook T Kim; Carol Reynolds; Sharmila Chamling Rai; Yohei Arihara; Tomohiro Kubo; Leutz Buon; Mahasweta Gooptu; John Koreth; Corey Cutler; Sarah Nikiforow; Vincent T Ho; Edwin P Alyea; Joseph H Antin; Catherine J Wu; Robert J Soiffer; Jerome Ritz; Rizwan Romee
Journal:  Blood Adv       Date:  2021-01-26

Review 2.  Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Justyna Ogonek; Mateja Kralj Juric; Sakhila Ghimire; Pavankumar Reddy Varanasi; Ernst Holler; Hildegard Greinix; Eva Weissinger
Journal:  Front Immunol       Date:  2016-11-17       Impact factor: 7.561

3.  Mucosal-Associated Invariant T Cells Display a Poor Reconstitution and Altered Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Martin Solders; Tom Erkers; Laia Gorchs; Thomas Poiret; Mats Remberger; Isabelle Magalhaes; Helen Kaipe
Journal:  Front Immunol       Date:  2017-12-21       Impact factor: 7.561

4.  Early CD8+-recovery independently predicts low probability of disease relapse but also associates with severe GVHD after allogeneic HSCT.

Authors:  Juha Ranti; Samu Kurki; Urpu Salmenniemi; Mervi Putkonen; Soile Salomäki; Maija Itälä-Remes
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

Review 5.  B Cell Reconstitution and Influencing Factors After Hematopoietic Stem Cell Transplantation in Children.

Authors:  Nicolaas G van der Maas; Dagmar Berghuis; Mirjam van der Burg; Arjan C Lankester
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

Review 6.  Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies.

Authors:  Elisa Zaghi; Michela Calvi; Clara Di Vito; Domenico Mavilio
Journal:  Front Immunol       Date:  2019-11-28       Impact factor: 7.561

Review 7.  Experimental Models of Infectious Pulmonary Complications Following Hematopoietic Cell Transplantation.

Authors:  Xiaofeng Zhou; Bethany B Moore
Journal:  Front Immunol       Date:  2021-08-16       Impact factor: 7.561

8.  Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.

Authors:  Christelle Retière; Catherine Willem; Thierry Guillaume; Henri Vié; Laetitia Gautreau-Rolland; Emmanuel Scotet; Xavier Saulquin; Katia Gagne; Marie C Béné; Berthe-Marie Imbert; Beatrice Clemenceau; Pierre Peterlin; Alice Garnier; Patrice Chevallier
Journal:  Oncotarget       Date:  2018-01-27

Review 9.  Adoptive T Cell Therapy Strategies for Viral Infections in Patients Receiving Haematopoietic Stem Cell Transplantation.

Authors:  Giorgio Ottaviano; Robert Chiesa; Tobias Feuchtinger; Mark A Vickers; Anne Dickinson; Andrew R Gennery; Paul Veys; Stephen Todryk
Journal:  Cells       Date:  2019-01-14       Impact factor: 6.600

Review 10.  T cell regeneration after immunological injury.

Authors:  Enrico Velardi; Jennifer J Tsai; Marcel R M van den Brink
Journal:  Nat Rev Immunol       Date:  2020-10-23       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.